Who We Are

Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector.

ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital firms, leading Research and Academic Institutes and Law Firms and Equipment Suppliers.

The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector.

ABLE thus catalyses a symbiotic interface between the industry, the government, academic and research institutes and domestic and international investors.

Executive Council

Ms. Kiran Mazumdar Shaw

Ms. Kiran Mazumdar Shaw

Hon. Non Executive Chairman ABLE

Chairman & Managing Director,
Biocon Limited

Kiran Mazumdar-Shaw, a pioneer of the biotechnology industry in India, is the founder of the country’s leading biotechnology enterprise, Biocon. Named among TIME magazine’s 100 most influential people in the world, Ms. Mazumdar-Shaw is recognized as a thought leader who has made her country proud by building a globally recognized biopharmaceutical enterprise that is committed to innovation and affordability in delivering best-in-class therapeutics to patients across the globe.

As a global influencer, she is ranked among “World's 25 Most Influential People in Biopharma” by Fierce Biotech, Forbes magazine’s “100 Most Powerful Women” and Fortune’s “Top 25 Most Powerful Women in Asia-Pacific”. She has been recognized as the only Indian on Forbes' list of “World's Self- Made Women Billionaires”. She has been conferred with the highest French distinction - Chevalier de l’Ordre National de la Légion d’Honneur (Knight of the Legion of Honour). She was bestowed with “The Global Leadership in Engineering Award” by Los Angeles-based USC Viterbi, School of Engineering in 2016 for excellence in biotechnology worldwide and most recently with the Advancing Women in Science and Medicine (AWSM) Award for Excellence 2017 by The Feinstein Institute for Medical Research, USA. She has also featured in “The Worldview 100 List” of the most influential visionaries by Scientific American magazine and named among the “100 Leading Global Thinkers” by Foreign Policy magazine. Also, featured among the top ten “Medicine Maker Power List”, an index of the 100 most influential people across the globe in the field of medicine, being recognized consecutively for the third year since 2015.

Mazumdar-Shaw received a graduate honours degree in Zoology from Bangalore University (1973) and qualified as a Master Brewer from Ballarat University, Australia (1975). Ms Shaw also received an honorary Doctorate of Science in 2004, from her alma mater, Ballarat University, in recognition of her pre-eminent contributions to the field of Biotechnology. She has also been awarded honarary doctorates from University of Abertay, Dundee, U.K. (2007), University of Glasgow, U.K. (2008) and Heriot-Watt University, Edinburgh, U.K. (2008).

Mazumdar-Shaw is Chairperson of the Board of Governors of the Indian Institute of Management, Bangalore, and has been appointed as Global Alumni Ambassador for Australia by the Department of Foreign Affairs and Trade, Australia. She is also on the board of advisors for The National Society of High School Scholars, US and is a founder member of the Society for the Institute for Stem Cell Biology and Regenerative Medicine, Bangalore. Ms Shaw chairs Karnataka's Vision Group on Biotechnology and also served on the Board of Science Foundation, Ireland. She has been appointed as a member of the high-level expert committee constituted by the Department of Biotechnology (DBT) to review the autonomous organizations under the administrative control of the department and more recently as a Governing Council Member of the National Institute of Immunology, an autonomous research institute of the DBT.

Mazumdar-Shaw is the recipient of several prestigious awards including the ET Businesswoman of the Year, Ernst & Young's Entrepreneur of the Year Award for Life Sciences & Healthcare, Technology Pioneer, etc. Her most cherished awards are the national awards, PADMASHRI (1989) and PADMA BHUSHAN (2005) presented to her by the President of India, for her pioneering efforts in Industrial Biotechnology.

Dr. P.M. Murali

Mr. Shrikumar Suryanarayan

Hon. President ABLE

Chairman, Sea6 Energy


Shrikumar is the Chairman and co-founder of Sea6 Energy Pvt. Ltd. He was formerly the President of Research and Development at Biocon Limited, Bangalore India (www.biocon.com) and the Chief Scientific Advisor to the company. He was associated with Biocon for over 25 years.

His other appointments include an Adjunct Professorship at the Department of Biotechnology at the Indian Institute of Technology Madras. He is also a member of Governing & Advisory boards of several institutes and centers promoted by the Department of Biotechnology, Government of India and served as the Chief Executive officer for the Translational Health Sciences Institute at the National Capital Region Biosciences Cluster, Government of India from 2009-2010.

Shrikumar has a Bachelor's degree in Chemical Engineering from Indian Institute of technology, Madras and a Master's degree in Biochemical Engineering from the Indian Institute of technology Delhi. In 2001, he was awarded the Biotechnology Process Development award of the Government of India and in 2009 he received the Distinguished Alumnus Award of the Indian Institute of Technology, Madras.

 Mr. Shrikumar Suryanarayan

Mr. G S Krishnan

Vice-President ABLE

Novozymes


G S Krishnan is the Regional President for Novozymes India. Novozymes is the world leader in industrial biotechnology and microorganisms. He drives Business developments, Strategic partnerships, Sustainability, Mergers & Acquisitions and Leadership development in India. He has been at the forefront of developing Novozymes business in India, as well as playing a leadership role in the Industrial Biotechnology segment for over 25 years.

During his tenure, Novozymes India has grown from a small organisation of 5 employees in 1991 to over 550 employees today. As Regional President, Krishnan has been actively involved in the strategic acquisition of Biocon’s enzyme business. He plays a thought leadership role, in close coordination with external stakeholders and decision makers, giving necessary inputs on industry policies and regulatory standards in the Industrial Biotech segment. He also drives Novozymes Sustainability agenda. He plays a key role on the overall strategy of Novozymes in India, providing Senior Management on both insights on business opportunities India, as well as the political and economic scenario in the Country. He is the Chairman of the Novozymes Indian Leadership Team.

Some of his external roles:

  1. Co-chiarman of the Confederation of Indian Industry’s ‘National committee on Wind & Bioenergy’,
  2. Member of the ‘Vision Group’ on Biotechnology, Government of Karnataka,
  3. Vice President of the ‘Association of Biotech Lead Enterprises’ (ABLE).

He holds a Bachelors degree in Applied Sciences (in the faculty of Engineering) from Coimbatore Institute of Technology and PGDMM from Annamali University.

He has undertaken the “Leading for Results” program from INSEAD Business School, Singapore.

Dr. Goutam Das

Dr. Goutam Das

General Secretary


Dr Goutam Das earned his Ph.D. in Biology from Indian Institute of Chemical Biology at Kolkata with a post doctoral training in the USA. He started his career with Astra Research Centre India (ARCI was a wholly owned subsidiary of Astra AB, Sweden, currently AstraZeneca Plc) at Bangalore conducting research programs at Bangalore site for Astra Hassle, Sweden. Following ARCI (1988 - 1994) joined a newly founded start up Syngene Intl Ltd as the first Director (later renamed as Chief Operating Officer) and stayed with the company for seventeen years (1994 - 2010).

Syngene is a wholly owned subsidiary of India's top biopharmaceutical company, Biocon. Since January 2011 have been associated with a number of companies and a "not for profit" international organization as a strategic advisor on a retainer basis.

Mr. Subramani Ramachandrapa

Dr. Anand Anandkumar

Treasurer ABLE

Co-Founder and CEO, Bugworks Research India Private Limited


Anand comes with hands-on expertise in diverse environments – from semiconductor-engineering to biotechnology; senior management roles to development of start-up ecosystem. Anand was previously Chairman and Managing Director at Cellworks Research India Pvt Ltd, a company that pioneered the use of Systems biology and semiconductor technologies in creating Directed therapies in Cancer-care. Prior to Cellworks, Anand was the co-founding Managing Director of the India operation of SpinCircuit (acquired by Cadence, 2003) and Magma Design Automation (acquired by Synopsys, 2011).

He has management, operations, and business development experience in the US, Europe, China and India regions. Anand received his MS and Ph.D. in Electrical & Biomedical Engineering from George Washington University, Washington DC, and BE (Hons) in ECE from Anna University. He is a member of Eta-Kappa-Nu and Tau-Beta-Pi International Engineering honors societies and is the co-inventor on patents ranging from Satellite communication, Pharmaceuticals to Clean Energy. He is co-founder of India Semiconductor Association (IESA), co-founder of EVA, a healthcare Accelerator, ex-General secretary of ABLE, member of Indo-American Chamber of Commerce, and a Charter member of TiE Bangalore.

Dr. Dhananjay B. Patankar

Dr. K K Narayanan, Member ABLE

Ex-Managing Director, Metahelix Life Sciences


Narayanan is one of the Founder Directors of Metahelix Life Sciences, a Tata enterprise. He graduated with a Ph.D. in plant breeding and genetics from the Tamil Nadu Agricultural University at Coimbatore, India. He later on carried out post-doctoral research at the department of biological sciences, Stanford University under a Rockefeller Foundation fellowship. Returning to India, he started his career as a scientist at the Spic Science Foundation, Chennai and later moved on to lead the crop transformation and functional genomics programme at the Monsanto Research Centre located within the Indian Institute of Science, Bangalore. In 2001, he along with four other scientist colleagues founded Metahelix Life Sciences. The company was later acquired by the Tata Group. Narayanan is a member of several committees and advisory bodies including several scientific task forces on “agricultural biotechnology” of the DBT, Government of India, and theVision Group on Biotechnology set up by the Karnataka government. He is currently mentoring a few startups in the agri-biotech segment. Narayanan is a former President of ABLE.

Dr. Dhananjay B. Patankar

Prof. Vijay Chandru, Member ABLE

Chairman and Managing Director, Strand Life Sciences


Vijay Chandru (Ph.D., MIT 1982) is an academic entrepreneur recognized as a ‘Technology Pioneer’ by the World Economic Forum in 2006. His academic career has spanned over two decades at Purdue University and the Indian Institute of Science. Chandru is the recipient of several awards and honors: Fellow of Indian Academy of Sciences (1996), MCIT Dewang Mehta Award for Innovation in IT (2001), UGC Hari Om Trust award for “Science and Society” (2003), the President’s Medal of INFORMS in 2006, distinguished Alumni award by the MIT India Program in 2007, and was recognized as the BioSpectrum Biotech Entrepreneur of 2007. Chandru was the elected Honorary President (2009-2012) of the Association of Biotech Led Enterprises (ABLE), the apex trade body that represents the Indian biotech industry. Chandru also serves as an advisor to the Karnataka State Council on Science & Technology and on the Atal Innovation Mission at the National Institution for Transforming India (NITI AAYOG) in New Delhi. He is also a member of Karnataka’s Vision Group on Biotechnology.

Dr. Dhananjay B. Patankar

Dr. P M Murali, Member ABLE

Chairman Golden Jubilee Biotech Park and MD & CEO of Evolva, India


Serial entrepreneur for more than two decades with many first of its kind products and innovations in many areas of biotechnology; Built pioneering IT green field projects. Was part of a Venture capital organization to evaluate prospective technologies for commercialization.

Murali has over 20 years of experience in pharmaceutical and health care R&D, including management of more than 10 clinical trials, in particular in respiratory diseases. Previously, he was Founder and Director (for 16 years) of Dalmia Centre for Research and Development, developing and launching natural product-based therapeutics, and Founder and Chairman of MLC & Netpeople group of IT & Telecom companies (networking solutions, banking security and communication services).

Murali is a former Indo-US scientist at Battelle-Kettering, Ohio, and fellow of Unilever India. He received a PhD in Microbiology and Microbial Technology from Madurai Kamaraj University. Dr. Murali was also the President of ABLE. He is on the Board of Dalmia Research and Development Limited and a member of the Governing Board of Dalmia Centre for Research and Development. Dr. Murali is Vice-President and Treasurer of the Indian Red Cross Society. He is also Chairperson of the Biotech panel of the Confederation of Indian Industrys Tamil Nadu and a member of the Vision Group of the Government of Karnataka.

Dr. Raja Mugasimangalam

Dr. Raja Mugasimangalam, Member ABLE

Founder and CEO Genotypic technology


Raja Mugasimangalam (Founder and CEO Genotypic technology, Bangalore India) is a former technocrat turned entrepreneur in the Genomics Business. Since 1998, he has been working in close collaboration with Biotech, Pharma, Agriculture / seed companies and academia helping them apply Sequencing, Bioinformatics and Microarray technologies to real life research projects. Genotypic has become the key player in Genomics in India and has led to creation of over 5 start-ups in the areas of molecular diagnostics.

Raja publishes actively in peer reviewed journals and is a reviewer in Journals like PLOSone and BMC Genomics. He is member of the board of studies in many universities for Genomics, Genome informatics and Bioinformatics and of several professional organizations like ABLE, IACR and Indian Biochemists Association. He spends a considerable time delivering seminars and lectures at colleges and universities and is popularizing the Genomics Hub concept for a wider application of Genomics and Informatics.

Prior to founding Genotypic Technology, he worked at Quark Biotech Inc (USA and Israel) developing methods for constructing Microarrays. He received his BSc in Biochemistry from PSG CAS (Coimbatore- 1986), Masters (1998) in Biotechnology from MKU and PhD (1994) in Biotechnology from Madurai Kamaraj University and worked as postdoctoral Scientist at Weizmann Institute of Science (Human Genome Project), Israel and Sidney Kimmel Cancer Center, San Diego USA. Raja worked at Argonne National lab (Chicago USA) on developing novel methods for DNA sequencing for Human Genome Project. At Genotypic, Raja collaborates with leading researchers, scientific institutions and pharma-biotech companies from all over the world. Genotypic is in the process of expanding into all the NGS sequencing technology platforms and applications with the goal of ameliorating the wetlab and analysis process and using them in optimal combination for biological research in various domains.

Raja runs the world’s largest Genomics linkedin Group: Genomics NGS and Microarrays with more than 32,000 followers.

Dr. Dhananjay B. Patankar

Mr. Ravi Bhola, Member ABLE

Patent Chair, K&S Partners


Ravi Bhola has handled filing and prosecution of few thousand patent applications for his clients across the world. These applications are in diverse areas of technology including biotechnology, bioinformatics, software, nanotechnology, pharmaceuticals, stem cells, and mechanical engineering. He has also handled filing and prosecution of several hundred design applications in various jurisdictions. He is a post-graduate in the field of biotechnology from Jawaharlal Nehru University (JNU), New Delhi and has extensively researched in the area of protein refolding.

Ravi specialized in the area of Intellectual Property Rights from the Indian Law Institute, New Delhi. Subsequently, he earned a Bachelor’s degree in Law from the University of Delhi and was admitted to the bar. He works very closely with several start-ups and spin-offs, coming out from academic institutions as well as from large corporations. He regularly conducts patent workshops and Invention Capturing Sessions for his clients.

Dr. Dhananjay B. Patankar

Dr. Shriram Ragavan, Member ABLE

Vice President, Evolva Biotech


Shriram, presently the Vice President at the Swiss MNC Evolva Biotech, has about 18 years of corporate research experience spanning diverse life science segments including conventional areas such as BioPharma, Bioinformatics, Diagnostics, Bioindustrial areas. He works for startups with disruptive innovation and participates in the management vision in nurturing them to success. Prior to Evolva, he had been part of FIVE startups with TWO successes and THREE failures. He has a Masters in biochemical engineering, M.Phil and Ph.D in computational systems biology, MBA in international business with focus on transfer pricing for biotechnology intangibles, and a certified “Key Executive Professional” from Harvard Business School in Boston, USA.

Dr. Dhananjay B. Patankar

Dr. Jayashree (Jay) Aiyar, Member ABLE

VP and Head, Discovery Biology, Syngene International Ltd


Jayashree holds a Ph. D in Immunology from the All India Institute of Medical Sciences, New Delhi and has pursued her post-doctoral research at the California Institute of Technology and the University of California at Irvine. She has over 25 years of global experience as a molecular pharmacologist and has been associated with leading global organizations like AstraZeneca, Merck, Ambrx Inc., Jubilant Biosys and Theravance. She has more than 30 peer-reviewed publications, three book chapters, seven patent applications and two issued patents to her credit. Prior to joining Syngene in 2016, Jayashree worked with Jubilant Biosys as Vice President and Head of Biology.

Dr. Dhananjay B. Patankar

Mr. Sujay Shetty, Member ABLE

Partner and Leader – India Pharmaceutical & Life Sciences, PwC India


Sujay is Pharma, Life sciences and Medical Devices sector leader for PwC India. He is a member of the Global Pharma Leadership team of PwC.

Sujay has over 20 years of industry experience in the Pharmaceutical & Medical Devices industry in India, US, UK & South East Asia. He has led four international companies at the board level (three of which were in the Pharma / Medical device industry) including two start ups where he was responsible for leading senior management teams and creating and executing corporate strategy. Sujay is a member of the Vision Group for Biotechnology for the state of Karnataka.

Prior to joining PriceWaterhouseCoopers, Sujay was with the corporate finance practices of the UK investment bank Lazard Brothers in London & UB group, Dubai. He is a chartered accountant, holds an MBA from the University of Chicago Booth School of Business, two Masters degrees in Law and Finance from the London School of Economics and executive education from Harvard Business School.

Secretariat & Consultants

Dr. Anil Ram Chauhan

Sr. Advisor Government relations


Ms. Guljit Chaudhry

Sr. Advisor Bio pharma



Narayanan Suresh

Chief Operating Officer


Suresh is an accomplished journalist and was the Group Editor of BioSpectrum, Asia’s first biotechnology published simultaneously from India and Singapore. A masters in Physics from Central University of Hyderabad, Suresh has covered India’s strides in science & technology, first for Times of India from Delhi and for CyberMedia and MM ActivSci-Tech Communications publications from Bangalore over the last three decades. Suresh was also the Group Editor of MIT Technology Review India Editior published for five years from India and anchored its EmTech Conference and selection Young Innovators under 35 for four years in India and Singapore.

For more than a decade, Suresh has championed the cause of India’s biotechnology sector and pioneered the annual ABLE-BioSpectrum Biotech Industry Survey since 2003, showcased the industry’s highlights around the world, built a highly successful media platform to engage the biotech industry across Asia-Paciifc and a communicator of the industry’s work to the student community and the public.

In the current role, Suresh will be striving to expand the footprint of ABLE to reach out to the entire biotech community and push it towards the goal of achieving a $ 100 billion BioEconomy in the country by 2025.

Pavana Praveen

Manager-Operations & Business Development


For any queries, please contact him at pavanapr@ableindia.org.in

Srinivas Rao Chandan

Sr. Consultant, Content


For any queries, please contact him at schandan@ableindia.org.in

Indrila Sengupta

Asst. Manager- Business Development and Operations


For any queries, please contact her at indrilas@ableindia.org.in